Aries Wealth Management - CORBUS PHARMACEUTICALS HLDGS ownership

CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.

Quarter-by-quarter ownership
Aries Wealth Management ownership history of CORBUS PHARMACEUTICALS HLDGS
ValueSharesWeighting
Q4 2022$1,702
-14.9%
15,4000.0%0.00%0.0%
Q3 2022$2,000
-50.0%
15,4000.0%0.00%
-50.0%
Q2 2022$4,000
-55.6%
15,4000.0%0.00%
-33.3%
Q4 2021$9,000
-62.5%
15,400
-34.2%
0.00%
-70.0%
Q3 2021$24,000
-44.2%
23,4000.0%0.01%
-44.4%
Q2 2021$43,000
+4.9%
23,4000.0%0.02%0.0%
Q1 2021$41,000
+24.2%
23,4000.0%0.02%
+12.5%
Q4 2020$33,000
-45.0%
23,400
-29.9%
0.02%
-52.9%
Q3 2020$60,000
-46.4%
33,400
+149.3%
0.03%
-50.0%
Q2 2020$112,000
-17.6%
13,400
-52.0%
0.07%
-34.6%
Q1 2020$136,000
-15.0%
27,9000.0%0.10%
+6.1%
Q4 2019$160,000
+35.6%
27,900
+9.8%
0.10%
+25.6%
Q3 2019$118,000
-36.9%
25,400
-7.3%
0.08%
-40.5%
Q2 2019$187,000
-1.6%
27,4000.0%0.13%
-7.7%
Q1 2019$190,000
+20.3%
27,400
+1.5%
0.14%
-15.5%
Q4 2018$158,000
-22.5%
27,0000.0%0.17%
-8.2%
Q3 2018$204,000
+50.0%
27,0000.0%0.18%
+45.2%
Q2 2018$136,000
-2.9%
27,000
+22.7%
0.13%
-7.4%
Q1 2018$140,000
-8.5%
22,000
+18.9%
0.14%
-3.5%
Q4 2017$153,00018,5000.14%
Other shareholders
CORBUS PHARMACEUTICALS HLDGS shareholders Q4 2019
NameSharesValueWeighting ↓
Knoll Capital Management, LLC 5,045,870$42,335,00024.44%
MANGROVE PARTNERS IM, LLC 552,200$4,633,0001.13%
ETF MANAGERS GROUP, LLC 3,707,912$31,109,0001.10%
Ikarian Capital, LLC 1,350,000$11,327,0000.90%
GENERAL AMERICAN INVESTORS CO INC 712,400$5,977,0000.76%
AdvisorShares Investments LLC 189,814$1,593,0000.68%
Ikarian Capital, LLC 1,000,000$8,390,0000.67%
Granite Point Capital Management, L.P. 1,123,600$9,427,0000.48%
Carmignac Gestion 3,773,440$31,659,0000.44%
Omnia Family Wealth, LLC 32,356$271,467,0000.27%
View complete list of CORBUS PHARMACEUTICALS HLDGS shareholders